Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/18/2023 | Surrozen, Inc./DE | | Grant | Option (right to buy) | 20k | $0.56 | $11.2k | | 05/18/2023 |
06/07/2022 | Surrozen, Inc./DE | | Grant | Option (right to buy) | 20k | $2.79 | $55.8k | | 06/07/2022 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 44k | $11.35 | $500k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 60k | $35.42 | $2.1M | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 55k | $67.31 | $3.7M | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Other | Common Stock | 3.8k | $100.00 | $379.9k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Other | Common Stock | 3.3k | $100.00 | $330.2k | See footnote | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 57k | $3.00 | $170.8k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 24.8k | $3.18 | $78.8k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 29.7k | $4.72 | $140.4k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 13.2k | $5.00 | $66k | | 09/28/2020 |
09/28/2020 | Principia Biopharma Inc. | PRNB | Disposition | Employee Stock Option (right to buy) | 34.7k | $7.27 | $252k | | 09/28/2020 |
08/18/2020 | Principia Biopharma Inc. | PRNB | Exercise | Employee Stock Option (right to buy) | 7.5k | $3.00 | $22.5k | | 08/18/2020 |
08/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 7.5k | $99.37 | $745.2k | | 08/18/2020 |
05/19/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 7.5k | $65.10 | $488.3k | | 05/19/2020 |
05/19/2020 | Principia Biopharma Inc. | PRNB | Exercise | Employee Stock Option (right to buy) | 5.7k | $3.00 | $17k | | 05/19/2020 |
03/05/2020 | Principia Biopharma Inc. | PRNB | Grant | Employee Stock Option (right to buy) | 55k | $67.31 | $3.7M | | 03/05/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 605 | $67.08 | $40.6k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 2.2k | $68.13 | $152.6k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 76 | $68.52 | $5.2k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Exercise | Employee Stock Option (right to buy) | 2.5k | $3.00 | $7.5k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 2.7k | $63.86 | $171.4k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 545 | $64.91 | $35.4k | | 02/18/2020 |
02/18/2020 | Principia Biopharma Inc. | PRNB | Sale | Common Stock | 1.4k | $65.94 | $89k | | 02/18/2020 |
03/01/2019 | Principia Biopharma Inc. | PRNB | Grant | Employee Stock Option (right to buy) | 60k | $35.42 | $2.1M | | 03/01/2019 |
01/26/2012 | MAP Pharmaceuticals, Inc. | MAPP | Payment of Exercise | Common Stock | 943 | $13.84 | $13.1k | | 01/25/2012 |
01/26/2012 | MAP Pharmaceuticals, Inc. | MAPP | Exercise | Restricted Stock Unit (RSU) | 2.2k | $0.00 | $0 | | 01/25/2012 |
01/25/2012 | MAP Pharmaceuticals, Inc. | MAPP | Grant | Restricted Stock Unit (RSU) | 11k | $0.00 | $0 | | 01/25/2012 |
01/25/2012 | MAP Pharmaceuticals, Inc. | MAPP | Grant | Stock Option (Right to Buy) | 32.5k | $14.09 | $457.9k | | 01/25/2012 |
03/24/2010 | MAP Pharmaceuticals, Inc. | MAPP | Exercise | Stock Option (Right to Buy) | 8k | $0.74 | $5.9k | | 03/23/2010 |
03/24/2010 | MAP Pharmaceuticals, Inc. | MAPP | Sale | Common Stock | 8k | $16.47 | $131.7k | | 03/23/2010 |
03/23/2010 | MAP Pharmaceuticals, Inc. | MAPP | Sale | Common Stock | 8k | $16.72 | $133.8k | | 03/23/2010 |
03/23/2010 | MAP Pharmaceuticals, Inc. | MAPP | Exercise | Stock Option (Right to Buy) | 8k | $0.74 | $5.9k | | 03/23/2010 |